newsfilter
← Latest News
GlobeNewswire·

Viela Bio Reports First Quarter 2020 Financial Results and Program Highlights

GAITHERSBURG, Md., May 13, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today...